Lanreotide Long-Acting Aqueous Gel
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Hormone Antagonist ->
Somatostatin Receptor Agonist -> Lanreotide Long-Acting Aqueous Gel
Lanreotide Long-Acting Aqueous Gel Definition
A long-acting aqueous gel preparation of lanreotide, a synthetic cyclic octapeptide analogue of somatostatin. Lanreotide inhibits the secretion of growth hormone (GH) by binding to pituitary somatostatin receptors, and may inhibit the release of various other hormones, including thyroid stimulating hormone (TSH) and the gastroenteropancreatic hormones insulin, glucagon and gastrin. This agent also decreases circulating total and free insulin-like growth factor 1 (IGF-I). Lanreotide exhibits a high binding affinity for somatostatin receptor 2 (SSTR-2) and a lesser binding affinity for SSTR-5. However, compared to octreotide, this agent is less potent in inhibiting the release of growth hormone from the pituitary gland.
Lanreotide Long-Acting Aqueous Gel Synonyms
Lanreotide Long-Acting Aqueous Gel, Lanreotide Autogel, Somatuline Autogel, lanreotide (long-acting aqueous preparation)
Terms in Lanreotide Long-Acting Aqueous Gel category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.